• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像评估标准在预测经导管主动脉瓣置换术使用自膨胀生物假体后扩张需求中的重要性

Importance of Imaging Assessment Criteria in Predicting the Need for Post-Dilatation in Transcatheter Aortic Valve Implantation with a Self-Expanding Bioprosthesis.

作者信息

Hammerer Matthias, Hasenbichler Philipp, Schörghofer Nikolaos, Knapitsch Christoph, Clodi Nikolaus, Hoppe Uta C, Hergan Klaus, Boxhammer Elke, Scharinger Bernhard

机构信息

Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.

Department of Radiology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.

出版信息

J Cardiovasc Dev Dis. 2025 Aug 1;12(8):296. doi: 10.3390/jcdd12080296.

DOI:10.3390/jcdd12080296
PMID:40863362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386964/
Abstract

BACKGROUND

Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of severe aortic valve stenosis (AS). Balloon post-dilatation (PD) remains an important procedural step to optimize valve function by resolving incomplete valve expansion, which may lead to paravalvular regurgitation and other potentially adverse effects. There are only limited data on the predictors, incidence, and clinical impact of PD during TAVI.

METHODS

This retrospective, single-center study analyzed 585 patients who underwent TAVI (2016-2022). Pre-procedural evaluations included transthoracic echocardiography and CT angiography to assess key parameters, including the aortic valve calcium score (AVCS); aortic valve calcium density (AVCd); aortic valve maximal systolic transvalvular flow velocity (AV Vmax); and aortic valve mean systolic pressure gradient (AV MPG). We identified imaging predictors of PD and evaluated associated clinical outcomes by analyzing procedural endpoints (according to VARC-3 criteria) and long-term survival.

RESULTS

PD was performed on 67 out of 585 patients, with elevated AV Vmax (OR: 1.424, 95% CI: 1.039-1.950; = 0.028) and AVCd (OR: 1.618, 95% CI: 1.227-2.132; = 0.001) emerging as a significant independent predictor for PD in TAVI. Kaplan-Meier survival analysis revealed no significant differences in short- and mid-term survival between patients who underwent PD and those who did not. Interestingly, patients requiring PD exhibited a lower incidence of adverse events regarding major vascular complications, permanent pacemaker implantations and stroke.

CONCLUSIONS

The study highlights AV Vmax and AVCd as key predictors of PD. Importantly, PD was not associated with increased procedural adverse events and did not predict adverse events in this contemporary cohort.

摘要

背景

经导管主动脉瓣植入术(TAVI)彻底改变了严重主动脉瓣狭窄(AS)的治疗方式。球囊后扩张(PD)仍然是一个重要的手术步骤,通过解决瓣膜扩张不完全的问题来优化瓣膜功能,瓣膜扩张不完全可能导致瓣周反流和其他潜在的不良影响。关于TAVI期间PD的预测因素、发生率和临床影响的数据有限。

方法

这项回顾性单中心研究分析了585例接受TAVI的患者(2016 - 2022年)。术前评估包括经胸超声心动图和CT血管造影,以评估关键参数,包括主动脉瓣钙化评分(AVCS)、主动脉瓣钙化密度(AVCd)、主动脉瓣最大收缩期跨瓣血流速度(AV Vmax)和主动脉瓣平均收缩期压力阶差(AV MPG)。我们确定了PD的影像学预测因素,并通过分析手术终点(根据VARC - 3标准)和长期生存率来评估相关的临床结果。

结果

585例患者中有67例进行了PD,AV Vmax升高(OR:1.424,95%CI:1.039 - 1.950;P = 0.028)和AVCd升高(OR:1.618,95%CI:1.227 - 2.132;P = 0.001)成为TAVI中PD的显著独立预测因素。Kaplan - Meier生存分析显示,接受PD的患者与未接受PD的患者在短期和中期生存率上没有显著差异。有趣的是,需要PD的患者在主要血管并发症、永久性起搏器植入和中风等不良事件的发生率较低。

结论

该研究强调AV Vmax和AVCd是PD的关键预测因素。重要的是,在这个当代队列中,PD与手术不良事件增加无关,也不能预测不良事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/0e1685a42be3/jcdd-12-00296-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/79e670f05330/jcdd-12-00296-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/f727ded7bf35/jcdd-12-00296-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/0e1685a42be3/jcdd-12-00296-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/79e670f05330/jcdd-12-00296-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/f727ded7bf35/jcdd-12-00296-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0e/12386964/0e1685a42be3/jcdd-12-00296-g003.jpg

相似文献

1
Importance of Imaging Assessment Criteria in Predicting the Need for Post-Dilatation in Transcatheter Aortic Valve Implantation with a Self-Expanding Bioprosthesis.影像评估标准在预测经导管主动脉瓣置换术使用自膨胀生物假体后扩张需求中的重要性
J Cardiovasc Dev Dis. 2025 Aug 1;12(8):296. doi: 10.3390/jcdd12080296.
2
Impact of Pre- and Post-Dilatation on Long-Term Outcomes After Self-Expanding and Balloon-Expandable TAVI.预扩张和后扩张对自膨胀式和球囊扩张式经导管主动脉瓣植入术长期预后的影响
J Funct Biomater. 2025 Aug 1;16(8):282. doi: 10.3390/jfb16080282.
3
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI).钠-葡萄糖协同转运蛋白2抑制剂对接受经导管主动脉瓣植入术(TAVI)的重度主动脉瓣狭窄糖尿病患者急性肾损伤的影响。
Cardiovasc Diabetol. 2025 May 21;24(1):221. doi: 10.1186/s12933-025-02773-x.
4
Health Related Quality of Life (HRQoL) after transcatheter aortic valve implantation in aortic stenosis patients: exploring a novel threshold for clinically significant improvement after 12 months.主动脉瓣狭窄患者经导管主动脉瓣植入术后的健康相关生活质量(HRQoL):探索12个月后具有临床显著改善的新阈值。
J Patient Rep Outcomes. 2025 May 26;9(1):58. doi: 10.1186/s41687-025-00894-1.
5
Three-Cusp View Orientation in TAVI: Evaluating LOA Versus Non-LOA Impact on Outcomes With Contemporary Valve Prostheses.经导管主动脉瓣置入术中的三尖瓣视图定位:评估瓣叶对合与非瓣叶对合对当代瓣膜假体预后的影响
Catheter Cardiovasc Interv. 2025 Aug 17. doi: 10.1002/ccd.70087.
6
Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis.经导管主动脉瓣置换术:球囊扩张式与自膨胀式生物瓣膜治疗二叶式主动脉瓣狭窄的比较
Circulation. 2025 Aug 18. doi: 10.1161/CIRCULATIONAHA.124.069323.
7
TAVI with the ACURATE neo2 in severe bicuspid aortic valve stenosis: the Neo2 BAV Registry.使用ACURATE neo2经导管主动脉瓣植入术治疗重度二叶式主动脉瓣狭窄:Neo2二叶式主动脉瓣注册研究
EuroIntervention. 2025 Jan 20;21(2):e130-e139. doi: 10.4244/EIJ-D-24-00869.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Transcatheter Aortic Valve Implantation With and Without Resheathing and Repositioning: A Systematic Review and Meta-analysis.经导管主动脉瓣植入术伴和不伴重新护套和重新定位:系统评价和荟萃分析。
J Am Heart Assoc. 2022 Jun 21;11(12):e024707. doi: 10.1161/JAHA.121.024707. Epub 2022 Jun 14.
10
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact.根据VARC-3标准评估经导管主动脉瓣置换术(TAVR)后的早期安全性:发生率、预测因素及临床影响。
Rev Esp Cardiol (Engl Ed). 2025 Jul;78(7):618-627. doi: 10.1016/j.rec.2024.12.005. Epub 2024 Dec 24.

本文引用的文献

1
Impact of balloon post-dilation on valve durability and long-term clinical outcomes after self-expanding transcatheter aortic valve implantation.球囊后扩张对自膨式经导管主动脉瓣植入术后瓣膜耐久性和长期临床结局的影响。
Catheter Cardiovasc Interv. 2024 Jan;103(1):209-218. doi: 10.1002/ccd.30907. Epub 2023 Nov 13.
2
Quantity and location of aortic valve calcification predicts paravalvular leakage after transcatheter aortic valve replacement: a systematic review and meta-analysis.主动脉瓣钙化的数量和位置可预测经导管主动脉瓣置换术后瓣周漏:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 May 24;10:1170979. doi: 10.3389/fcvm.2023.1170979. eCollection 2023.
3
A 20-year journey in transcatheter aortic valve implantation: Evolution to current eminence.
经导管主动脉瓣植入20年历程:发展至当前的卓越地位。
Front Cardiovasc Med. 2022 Nov 21;9:971762. doi: 10.3389/fcvm.2022.971762. eCollection 2022.
4
Pre-dilation and Post-dilation in Transcatheter Aortic Valve Replacement: Indications, Benefits and Risks.经导管主动脉瓣置换术中的预扩张和后扩张:适应症、益处和风险
Interv Cardiol. 2021 Oct 12;16:e28. doi: 10.15420/icr.2020.35. eCollection 2021 Apr.
5
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
6
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.瓣膜学术研究联合会 3 期:主动脉瓣临床研究更新的终点定义。
Eur Heart J. 2021 May 14;42(19):1825-1857. doi: 10.1093/eurheartj/ehaa799.
7
Echocardiographic assessment of aortic stenosis: a practical guideline from the British Society of Echocardiography.主动脉狭窄的超声心动图评估:英国超声心动图学会实用指南
Echo Res Pract. 2021 Apr 28;8(1):G19-G59. doi: 10.1530/ERP-20-0035.
8
The path of transcatheter aortic valve implantation: from compassionate to low-risk cases.经导管主动脉瓣植入术的发展历程:从同情性治疗到低风险病例。
Eur Heart J Suppl. 2020 Nov 18;22(Suppl L):L140-L145. doi: 10.1093/eurheartj/suaa154. eCollection 2020 Nov.
9
Incidence, Predictors, and Outcome of Paravalvular Leak after Transcatheter Aortic Valve Implantation.经导管主动脉瓣置换术后瓣周漏的发生率、预测因素和转归。
J Interv Cardiol. 2020 May 22;2020:8249497. doi: 10.1155/2020/8249497. eCollection 2020.
10
The role of echocardiography in transcatheter aortic valve implantation.超声心动图在经导管主动脉瓣植入术中的作用。
Cardiovasc Diagn Ther. 2018 Feb;8(1):3-17. doi: 10.21037/cdt.2018.01.06.